Hostname: page-component-7c8c6479df-r7xzm Total loading time: 0 Render date: 2024-03-28T20:47:08.827Z Has data issue: false hasContentIssue false

Varieties of decisional incapacity: Theory and practice

Published online by Cambridge University Press:  02 January 2018

Scott Y. H. Kim*
Affiliation:
Department of Bioethics, 10 Center Drive, 1C118, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892, USA. Email: scott.kim@nih.gov
Rights & Permissions [Opens in a new window]

Summary

Evaluation of decision-making capacity (DMC) for treatment is challenging. Owen et al, in this issue of the Journal, compare the abilities (understanding, appreciation and reasoning) relevant to DMC in medical and psychiatric patients. Here I discuss three key issues their article raises and that are relevant to the direction of future research.

Type
Editorial
Copyright
Copyright © Royal College of Psychiatrists, 2013 

Patients' authority to make their own medical decisions is ordinarily presumed, but when there are concerns about potential decisional impairment, the modern practice is to assess whether they retain sufficient amount and type of abilities relevant to decision-making. This function-based framework - in contrast to an appeal to a diagnosis or a label (‘unsound mind’) - for determining patients' decision-making capacity (DMC) reflects the high priority we now place on patient self-determination. It is agreed (see the Mental Capacity Act 2005 and Grisso & Appelbaum Reference Grisso and Appelbaum1 ) that the functional abilities necessary for DMC include the abilities to understand (i.e. intellectually absorb) the relevant information and to communicate a choice. There is less agreement on what essential abilities lie between the taking in of information and the expression of choice. Depending on the jurisdiction, these abilities may include appreciation (ability to form adequate beliefs regarding their situation) and reasoning (using or manipulating the information in some minimally adequate way), Reference Grisso and Appelbaum1 or, as stated in the Mental Capacity Act 2005, ‘using or weighing’ information to reach a decision.

The law states these broad criteria with relatively sparse definitions and it expects each clinician evaluator to apply them much as a judge would, in effect approximating what a court's judgment would be. Reference Grisso and Appelbaum1 However, unlike a judge in a controlled court room, the busy clinician faces significant time constraints and higher frequency of cases, with little or no legal training. Treatment DMC evaluation is also different from other types of forensic evaluations because they are not usually initiated as part of legal proceedings and occur instead as routine clinical problems. Reference Kim2 Clinicians find capacity evaluations quite challenging to perform. Reference Seyfried, Ryan and Kim3

It is this context that makes the analysis by Owen et al Reference Owen, Szmukler, Richardson, David, Raymont and Freyenhagen4 in this issue of the Journal particularly useful. They examined the interaction between the most widely cited criteria for capacity (understanding, appreciation and reasoning) with varying types of conditions impairing DMC, by comparing patients from a psychiatric hospital (55% of whom had psychoses or mania) and a medical hospital (at least 25% of whom had cognitive impairment with a Mini-Mental State Examination <24). In the original studies from which the data were drawn, understanding, appreciation and reasoning abilities were measured by an experienced psychiatrist using the MacArthur Competence Assessment Tool-Treatment (MacCAT-T), which yields dimensional scores for each ability; the MacCAT interview along with other available clinical information were then used by the psychiatrist to arrive at a categorical (yes v. no) determination of DMC. Although this retrospective analysis lacked some relevant clinical information (for example, cognition-related diagnoses among the medical in-patients), it still yielded important insights. I shall comment on three points, with an eye towards what the results might mean for future DMC research.

Impaired understanding in evaluating DMC in both medical and psychiatric patients

First, although it is tempting to emphasise the differences between the two patient groups' performance on the three criteria for DMC, we should begin with what they have in common. The authors found that in both hospital groups, about a quarter had poor understanding (defined as ⩽50% score on the understanding subscale); having poor understanding was a strong indicator of incapacity regardless of hospital group, with 81-93% lacking DMC. Those with poor understanding scores who lacked DMC generally also had poor appreciation and reasoning scores. This makes sense because if someone cannot absorb information then it is difficult to form beliefs about it or manipulate it (analogous to someone with impaired attention who appears to have poor short-term memory). Although it is not surprising that 67% of those with incapacity among medical patients had poor understanding (where one would expect cognitive dysfunction more than psychopathology to drive impairment), it is notable that almost half (44%) of the psychiatric patients lacking decisional capacity had poor understanding. This is consistent with previous studies of psychiatric patients (those with chronic psychoses) showing that cognitive impairment, rather than classic positive psychotic symptoms, can be the primary source of incapacity for many people in this patient group. Reference Palmer and Savla5,Reference Carpenter, Gold, Lahti, Queern, Conley and Bartko6 At any rate, clinicians should remain aware that lack of understanding accounts for nearly half of cases of incapacity even among psychiatric patients.

What is the theoretical and empirical significance of impaired reasoning?

Second, the theory behind DMC says that understanding is not sufficient for intact capacity and the authors confirmed this: 39% of psychiatric patients who showed good understanding nevertheless lacked DMC - virtually all of them had poor scores on appreciation, whereas only 17% had poor scores on reasoning. These are presumably patients who, despite their intellectual comprehension and intact reasoning, are unable to form adequate beliefs about their illness or treatment - a pattern attributable to their psychopathology (such as delusions) more than to cognitive impairment.

In contrast, among the medically ill, few patients with good understanding lacked DMC (13%). Everyone (12 of 12) in this small group lacking DMC scored poorly on reasoning yet most (10 of 12) had good scores on the appreciation task. These patients who were apparently determined to be lacking in DMC solely on the basis of poor reasoning present somewhat of a puzzle because they do not fit neatly into our normative understanding of incapacity. A comprehensive legal review by the authors of the MacCAT instruments found that poor reasoning is not used by the courts as a sole basis for finding someone as incapable. Reference Berg, Appelbaum and Grisso7 There are several potential explanations for this apparent discrepancy.

It may be a reflection of the fact that operationalisation of the reasoning ability in the MacCAT instrument is based on psychological, rather than legal, concepts, such that an expectation of close tracking between historical legal findings and clinical determinations using MacCAT may not be warranted. Reference Kim2 Also, we do not know whether the clinicians themselves justified their determinations of these patients' status using the reasoning standard - perhaps, for instance, despite ‘good’ understanding scores, the clinicians focused on the patients' failure to understand or appreciate specific items of particular import or that a 50% threshold for a ‘good’ score is insufficiently sensitive to detect understanding impairment sufficient for incapacity (after all, the 50% cut-off is somewhat arbitrary and low). Or, finally, it could be that UK clinicians in fact do use reasoning as a standalone standard, unlike in US courts. An in-depth qualitative analysis of these patients' interviews may yield insights. It would be instructive to find out just what kind of reasoning deficiency is compatible with intact understanding and appreciation and yet serious enough to merit a determination of incapacity. In this way, an empirical analysis could inform our normative discussions.

Research challenges arising from the context-specific nature of DMC

Finally, this analysis provided an important opportunity to examine a key methodological question about ‘real-world’ DMC studies. This study had important strengths: the subjects were real patients and the DMC capacity assessed was for real treatment decisions (albeit not real time). Further, the authors had available well-validated categorical DMC judgments (which is surprisingly uncommon in DMC research), making it possible for them to assess the relationship between the dimensional aspect of individual abilities with a categorical outcome variable for DMC. The methodological question arises from the fact that DMC assessment must be tailored to a particular decision, taking into account key contextual factors. Reference Grisso and Appelbaum1,Reference Kim2 Thus, some argue that the level of abilities needed to consent to psychiatric hospital admission should be lower than that needed for other decisions. Reference Appelbaum, Appelbaum and Grisso8 Also, whether patients consent to or refuse a treatment raises different risk-benefit considerations. Reference Grisso and Appelbaum1,Reference Kim2,Reference Buchanan and Brock9 Psychiatrists in fact use differential thresholds depending on the risk-benefit context of the decision. Reference Kim, Caine, Swan and Appelbaum10 Thus, it is possible that a competent patient (agreeing to an in-patient admission) could actually have worse performance on ability measures than someone deemed incompetent (but refusing to undergo an operation that is minimally burdensome but lifesaving). This potential variability in the meaning of the main outcome variable could present a significant complication to ‘real-world’ DMC studies.

The results of the Owen et al analysis are reassuring in that decision-specific DMC judgments by clinicians, even for a variety of medical and psychiatric decisions, still allowed detection of important associations between levels of ability and categorical DMC status. It may be that the risk-benefit range of the decisions was not sufficiently wide enough to affect categorical judgments. Or perhaps patients with relatively intact capacity tended to agree with recommended treatment whereas the more impaired patients were more likely to refuse - in which case the associations between categorical status and dimensional performance scores would be accentuated. (This might also explain the remarkably high reliability of categorical judgments among the clinician evaluators in this study.) As we conduct more real-world studies using actual patients' categorical DMC status, this is an aspect of the modern theory of DMC that researchers should incorporate into their work by explicitly including, for example, the valence of the patient's choice (acceptance or refusal of recommended treatment) in the analysis.

Conclusions

The rigorous interplay between theoretical and empirical inquiry exhibited in the Owen et al paper provides important insights and serves as a model for a new generation of DMC research. The modern framework for DMC assessment is ethically appealing because of its function-based and decision-specific focus. But such a framework has, as it were, many complex moving parts that require careful theoretical and empirical study if we are to provide a valid and reliable knowledge-base for busy clinicians who are asked to conduct DMC evaluations.

Acknowledgement

The views expressed are the author's; they do not represent any position or policy of the National Institutes of Health, the Department of Health and Human Services or the US government.

References

1 Grisso, T, Appelbaum, PS. Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals. Oxford University Press, 1998.CrossRefGoogle Scholar
2 Kim, SYH. Evaluation of Capacity to Consent to Treatment and Research. Oxford University Press, 2010.Google Scholar
3 Seyfried, L, Ryan, KA, Kim, SYH. Assessment of decision-making capacity: views and experiences of consultation psychiatrists. Psychosomatics 2013; 54: 115–23.Google Scholar
4 Owen, GS, Szmukler, G, Richardson, G, David, AS, Raymont, V, Freyenhagen, F, et al Decision-making capacity for treatment in psychiatric and medical in-patients: cross-sectional, comparative study. Br J Psychiatry 2013: 203: 461–7.CrossRefGoogle ScholarPubMed
5 Palmer, BW, Savla, GN. The association of specific neuropsychological deficits with capacity to consent to research or treatment. J Int Neuropsychol Soc 2007; 13: 1047–59.Google Scholar
6 Carpenter, WT Jr, Gold, JM, Lahti, AC, Queern, CA, Conley, RR, Bartko, JJ, et al Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry 2000; 57: 533–8.Google Scholar
7 Berg, JW, Appelbaum, PS, Grisso, T. Constructing competence: formulating standards of legal competence to make medical decisions. Rutgers Law Rev 1996; 48: 345–96.Google Scholar
8 Appelbaum, BC, Appelbaum, PS, Grisso, T. Competence to consent to voluntary psychiatric hospitalization: a test of a standard proposed by APA. Psychiatr Serv 1998; 49: 1193–6.CrossRefGoogle ScholarPubMed
9 Buchanan, AE, Brock, DW. Deciding for Others: The Ethics of Surrogate Decision Making. Cambridge University Press, 1989.Google Scholar
10 Kim, SYH, Caine, ED, Swan, JG, Appelbaum, PS. Do clinicians follow a risk-sensitive model of capacity determination? An experimental video survey. Psychosomatics 2006; 47: 325–9.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.